Clinical Trials Logo

Clinical Trial Summary

Many persons with autonomic failure often have high blood pressure when lying down (supine hypertension). This study is exploring the impact of decreased venous return to the heart (achieved by raising the head of the bed) to lessen supine blood pressure. If decreased venous return to the heart is effective at lowering supine blood pressure, these approaches may be utilized to treat supine hypertension non-pharmacologically. Raising the head of the bed decreases the amount of blood returning to the heart due to the effects of gravity. In this case, the decreased blood return to the heart may decrease blood pressure.


Clinical Trial Description

Autonomic failure (AF) is a severely disabling condition, which is characterized by orthostatic hypotension (severe drop in blood pressure upon standing), bladder and bowel dysfunction, and sexual dysfunction. Besides disabling orthostatic hypotension, however, half of these patients have supine hypertension (high blood pressure when lying). Sustained high blood pressure is a cardiac risk for heart disease, kidney disease, and stroke. Sustained supine hypertension during the night induces pressure natriuresis (increased urine production due to high blood pressure) and volume loss (due to frequent urination/high volumes of urine), worsening orthostatic hypotension the following morning (blood pressure falls even more when the blood volume has been decreased due to loss of fluids in urine) and may also complicate the treatment of orthostatic hypotension with pressor agents (giving a blood pressure pill to prevent overnight high blood pressure may make daytime standing blood pressure worse). Upright posture induces significant gravitational pooling of blood in the lower body that is normally compensated for by sympathetic activation. Failure of compensatory sympathetic activation results in orthostatic hypotension in autonomic failure patients due to the reduction in venous return and cardiac output. This abnormality has been used in autonomic failure patients with supine hypertension to their benefit by having them sleep with the head of the bed tilted up. The recommended amount of head up tilt is 10°, or about a 9-inch elevation of the head of the bed. In the investigators' hands this degree of tilt produces a significant but only modest decrease in blood pressure. Compliance is a limiting factor because most patients (and their spouses) are not able to tolerate even this modest level of head up tilt. Participants often elevate just the torso overnight, but the effect of this approach on supine blood pressure has not been reported.The investigators would like to compare the effects of tilt versus only elevating the head on supine blood pressure. The existing knowledge provides the rationale for the study of the elevation of the head of the bed as a non-pharmacologic approaches for the treatment of supine hypertension in these patients. Elevation of the head of the bed will decrease venous return to the heart using the effects of gravity. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04502225
Study type Interventional
Source Vanderbilt University Medical Center
Contact Bonnie K Black, RN
Phone 615-343-6862
Email bonnie.black@vumc.org
Status Recruiting
Phase N/A
Start date August 21, 2020
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT03593512 - Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy N/A
Recruiting NCT03648905 - Clinical Laboratory Evaluation of Chronic Autonomic Failure
Recruiting NCT03312556 - Treatment of Supine Hypertension in Autonomic Failure (CPAP) N/A
Recruiting NCT02897063 - Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Phase 1
Completed NCT01223391 - Abdominal Compression in Orthostatic Hypotension N/A
Recruiting NCT04620382 - Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients Early Phase 1
Completed NCT03900000 - Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's Disease N/A
Active, not recruiting NCT00678145 - Mechanisms of Hypoglycemia Associated Autonomic Failure Phase 2
Completed NCT00223691 - Treatment of Orthostatic Hypotension in Autonomic Failure Phase 1
Recruiting NCT03482297 - Automated Abdominal Binder for Orthostatic Hypotension Phase 1/Phase 2
Recruiting NCT05489575 - CPAP for the Treatment of Supine Hypertension N/A
Completed NCT00359346 - Plasma Exchange for Autoimmune Autonomic Failure N/A
Recruiting NCT03042988 - Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension N/A
Not yet recruiting NCT05908760 - CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study N/A
Recruiting NCT04782830 - Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms N/A
Recruiting NCT04246437 - [18F]F-DOPA Imaging in Patients With Autonomic Failure Phase 1
Recruiting NCT02429557 - Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure Phase 1
Completed NCT02417415 - Local Heat Stress in Autonomic Failure Patients With Supine Hypertension N/A
Completed NCT03681080 - Concentration and Attentional Deficits in POTS and Other Autonomic Neuropathies N/A